Zephyros Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 13767.19%
(FY 2023)
- Profit 29.21%
(FY 2023)
- Ebitda 43.94%
(FY 2023)
- Net Worth -112.48%
(FY 2023)
- Total Assets 5.28%
(FY 2023)
About Zephyros Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Parveen Dhir and Bal Krishan serve as directors at the Company.
- CIN/LLPIN
U24230CH2019PTC042625
- Company No.
042625
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Zephyros Pharmaceuticals Private Limited offer?
Zephyros Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Anti Ulcer Drugs, Farming Tools, Equipment & Machines, Disinfectant Sprayers, Common Disease Medicines, Pharmaceutical Tablets, Termite & Pest Control Services, Fumigation Services.
Who are the key members and board of directors at Zephyros Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parveen Dhir  | Director | 18-Jul-2019 | Current |
| Bal Krishan | Director | 18-Jul-2019 | Current |
Financial Performance of Zephyros Pharmaceuticals.
Zephyros Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13767.19% increase. The company also saw a substantial improvement in profitability, with a 29.21% increase in profit. The company's net worth observed a substantial decline by a decrease of 112.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zephyros Pharmaceuticals?
Unlock access to Zephyros Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Somsarovar Beverages Private LimitedActive 5 years 23 days
Parveen Dhir and Bal Krishan are mutual person
- B C I Bearings Private LimitedActive 37 years 3 months
Parveen Dhir and Bal Krishan are mutual person
- Lavishlane Hospitality Private LimitedActive 1 year 1 month
Parveen Dhir and Bal Krishan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zephyros Pharmaceuticals?
Unlock and access historical data on people associated with Zephyros Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zephyros Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zephyros Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
